A clinical trial to evaluate the procedure of taking patient own blood just before the start of surgery and giving it back to the patient at the end in Brain operations.
- Conditions
- Health Condition 1: D320- Benign neoplasm of cerebral meningesHealth Condition 2: Q079- Congenital malformation of nervoussystem, unspecifiedHealth Condition 3: C719- Malignant neoplasm of brain, unspecified
- Registration Number
- CTRI/2020/06/025965
- Lead Sponsor
- Dr Manbir Kaur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.All patients with American Society of Anaesthesiologist (ASA) grade 1 and grade 2
2.Patients of either sex
3.Age 18 years and above
4.Patients with haemoglobin greater than 11 g/dl
5.Patients with intracranial meningiomas and other high grade vascular tumors/ vascular malformations with estimated blood loss greater than 500 ml - 1 litre.
1.Patients with haemoglobin less than 11 g/dl
2.Patients with impaired renal or hepatic function
3.Pregnant women
4.Patients with deranged coagulation profile
5.Patients with coagulation disorders or patients on anticoagulants
6.Patients with a history of ischemic heart diseases, history of myocardial infarction, or patients with fixed cardiac output states.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary objective is to evaluate the difference between hemoglobin and hematocrit parameters in both the groups.Timepoint: intraoperatively, at the end of surgery and postoperatively
- Secondary Outcome Measures
Name Time Method 1)Perioperative hemodynamics in both the groups. <br/ ><br>2)Perioperative blood loss in both the groups. <br/ ><br>3)Perioperative need for allogenic blood transfusion in both the groups. <br/ ><br>4)Perioperative platelet count and coagulation parameters in both groups. <br/ ><br>5)Perioperative arterial blood gases in both groups. <br/ ><br>6)Perioperative complications in each group. <br/ ><br>7)Overall ICU stay and Length of hospital stay in each group. <br/ ><br>Timepoint: intraoperatively, at the end of surgery and postoperatively